These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6142906)

  • 21. Enhanced effect of triazolam with diltiazem.
    Kosuge K; Nishimoto M; Kimura M; Umemura K; Nakashima M; Ohashi K
    Br J Clin Pharmacol; 1997 Apr; 43(4):367-72. PubMed ID: 9146848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Flurazepam, temazepam, and triazolam.
    Greenblatt DJ; Harmatz JS; Engelhardt N; Shader RI
    Arch Gen Psychiatry; 1989 Apr; 46(4):326-32. PubMed ID: 2564763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of ingestion time interval on the interaction between itraconazole and triazolam.
    Neuvonen PJ; Varhe A; Olkkola KT
    Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam.
    Abernethy DR; Greenblatt DJ; Divoll M; Smith RB; Shader RI
    Clin Pharmacokinet; 1984; 9(2):177-83. PubMed ID: 6143633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninteraction of temazepam and cimetidine.
    Greenblatt DJ; Abernethy DR; Divoll M; Locniskar A; Harmatz JS; Shader RI
    J Pharm Sci; 1984 Mar; 73(3):399-401. PubMed ID: 6143815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
    Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive assay for triazolam in plasma following low oral doses.
    Edeki T; Robin DW; Prakash C; Blair IA; Wood AJ
    J Chromatogr; 1992 May; 577(1):190-4. PubMed ID: 1400742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo.
    Roehrs T; Zwyghuizen-Doorenbos A; Roth T
    Sleep; 1993 Jun; 16(4):301-5. PubMed ID: 8341890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodiazepine drug-drug interactions commonly occurring in clinical practice.
    Abernethy DR; Greenblatt DJ; Ochs HR; Shader RI
    Curr Med Res Opin; 1984; 8 Suppl 4():80-93. PubMed ID: 6144465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of influence of cigarette smoking on triazolam pharmacokinetics.
    Ochs HR; Greenblatt DJ; Burstein ES
    Br J Clin Pharmacol; 1987 Jun; 23(6):759-63. PubMed ID: 3606935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
    Jochemsen R; Wesselman JG; van Boxtel CJ; Hermans J; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):291S-297S. PubMed ID: 6140948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pharmacokinetic drug interaction between erythromycin and triazolam.
    Phillips JP; Antal EJ; Smith RB
    J Clin Psychopharmacol; 1986 Oct; 6(5):297-9. PubMed ID: 3771812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ranitidine on the pharmacokinetics of triazolam and alpha-hydroxytriazolam in both young (19-60 years) and older (61-78 years) people.
    O'Connor-Semmes RL; Kersey K; Williams DH; Lam R; Koch KM
    Clin Pharmacol Ther; 2001 Aug; 70(2):126-31. PubMed ID: 11503006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration.
    Smith RB; Kroboth PD; Phillips JP
    J Clin Pharmacol; 1986 Feb; 26(2):120-4. PubMed ID: 3950055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral triazolam sedation in implant dentistry.
    Goodchild JH
    J Oral Implantol; 2005; 31(2):105; author reply 105-6. PubMed ID: 15871531
    [No Abstract]   [Full Text] [Related]  

  • 37. Amoxicillin kinetics and ethanol ingestion.
    Morasso MI; Hip A; Márquez M; González C; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):428-31. PubMed ID: 3198295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
    Abernethy DR; Greenblatt DJ; Morse DS; Shader RI
    Br J Clin Pharmacol; 1985 Jan; 19(1):51-7. PubMed ID: 2858217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole.
    Varhe A; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):601-7. PubMed ID: 7995001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ranitidine on the disposition of orally and intravenously administered triazolam.
    Vanderveen RP; Jirak JL; Peters GR; Cox SR; Bombardt PA
    Clin Pharm; 1991 Jul; 10(7):539-43. PubMed ID: 1860302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.